ASCIA News

  • PBS listing of Dupixent (dupilumab) for severe atopic dermatitis
    From 1st March 2021, Dupixent (dupilumab) is listed on the Pharmaceutical Benefits Scheme (PBS) in Australia for the treatment of patients, 12 years and above, with severe atopic dermatitis, who have failed to respond to optimally prescribed topical treatments. Dupixent is a...
  • ASCIA 2021 Conference Update
    The ASCIA 2021 Conference is now being hosted as a virtual event across three days, from Wednesday 1st to Friday 3rd September 2021. The program will include: Sessions from 10.00-17.30 AEST each day (08.00-15.30 AWST, 09.45-17.00 ACST, 12.00-19.30 NZST). Sponsored sessions of 45...
  • ASCIA and WAO COVID-19 vaccine updates
    The ASCIA COVID-19 webpage www.allergy.org.au/members/covid-19 (including the FAQ and Position Statement) has been updated with the publications listed below. COVID-19 vaccination decision guide for women who are pregnant, breastfeeding, or planning pregnancy has been...
  • Signs and Symptoms of Allergic Reactions
    Whilst the ASCIA Action Plan for Anaphylaxis has included infographics for several years, the ASCIA website has not previously included images of signs/symptoms of allergic reactions. To address this, an ASCIA webpage showing signs/symptoms of allergic reactions has been...
  • New ASCIA Quick Reference Guides for COVID-19 Vaccination
    As a result of recent ASCIA meetings with the Australian Technical Advisory Group on Immunisation (ATAGI), the following one page guides have been developed: Allergy and COVID-19 Vaccination - Guide for health professionals New Immunodeficiency, Autoimmunity and COVID-19...
  • Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination Frequently Asked Questions (FAQ)
    24 February 2021   This information has been developed by ASCIA, the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand, to answer questions regarding COVID-19 vaccination in relation to allergy, immunodeficiency and autoimmunity. ASCIA...
  • ASCIA COVID-19 Update
    The ASCIA COVID-19 Working Party has developed the following two new documents to provide guidance about allergy, immunodeficiency, autoimmunity and COVID-19 vaccination, in preparation for the COVID-19 vaccination programs in Australia and New Zealand: Allergy,...
  • Australia Day 2021 Honours for ASCIA Members
    28 January 2021:  ASCIA congratulates the following ASCIA members who received Australia Day honours this year: A/Professor Richard Loh OAM, awarded for his service to medicine, particularly to clinical immunology.          https://honours.pmc.gov.au/honours/awards/2008192 A/Professor Sheryl Van Nunen OAM, awarded for...

  • Site updated: 27 Feb 2021


ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...

Join our mailing list here...

AIFA: Donate Now
AIFA: Donate Now
National Allergy Strategy
National Allergy Strategy
ASCIA: WAO Member
ASCIA: WAO Member
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.